Status:

COMPLETED

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Lead Sponsor:

Azidus Brasil

Conditions:

Psoriasis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The Psoriasis and a chronic dermatosis characterized by abnormal proliferation of cells epithelial, vessel dilation and inflammation locally, which presents erythematous-scaly lesions in various areas...

Detailed Description

The patients eligible will be informed about the procedures of the study and that agree to participate and sign the TCLE will be initially evaluated clinically for the clinical diagnosis of psoriasis ...

Eligibility Criteria

Inclusion

  • Patients of both sexes, adults over 18 years, holders of psoriasis plating of mild to moderate,
  • Patients with area of involvement of up to 20% of body surface,
  • Patients with good physical and mental health
  • Patients who agree with the purposes of the study and sign the Informed Consent

Exclusion

  • Patients with skin diseases other than psoriasis or which alter the clinical evaluation and development of disease,
  • Patients with psoriasis in more than 20% of the body,
  • Patients with other types of psoriasis that are not "plating",
  • patient with a scalp psoriasis who have difficulty in application of the product,
  • Patients who have made topical treatment for psoriasis in the 2 months preceding the study,
  • Patients who have made systemic treatment for psoriasis in the 4 months preceding the study,
  • Patients who do not agree with the conditions described in the Statement of Informed Consent
  • Patients who are pregnant and breastfeeding,
  • Patients in use of oral anticoagulants,
  • Patients who have psoriatics addition to plaques of skin disorders caused by fungi or bacteria.

Key Trial Info

Start Date :

July 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2010

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT00715975

Start Date

July 1 2008

End Date

August 1 2010

Last Update

September 2 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lal Clinica

Valinhos, São Paulo, Brazil, 13270000